secwatch.observer — SEC 8-K summary
======================================

Issuer:     CARDINAL HEALTH INC (CAH)
CIK:        0000721371
Form:       8-K
Filed at:   2022-08-11T23:59:59+00:00
Accession:  0000721371-22-000054
Event type: leadership
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cardinal Health appoints CFO Jason Hollar as CEO; Q4 revenue up 11% to $47.1B
-----------------------------------------------------------------------------

- Jason Hollar, current CFO, becomes CEO effective Sept 1, 2022; Mike Kaufmann steps down.
- Patricia English named interim CFO; external search for permanent CFO underway.
- Q4 FY22 revenue $47.1B (+11% YoY); non-GAAP diluted EPS $1.05 (+36%).
- Full year GAAP loss of $3.35/share due to $2.1B Medical segment goodwill impairment.
- FY2023 guidance: non-GAAP EPS $5.05-$5.40; share repurchases $1.5B-$2.0B; Medical Improvement Plan targets profit >=$650M by FY2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/721371/000072137122000054/0000721371-22-000054-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/721371/000072137122000054/cah-20220811.htm
  HTML page:      https://secwatch.observer/filing/0000721371-22-000054

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer